Spero Therapeutics (NASDAQ:SPRO) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Spero Therapeutics beat estimated earnings by 24.24%, reporting an EPS of $-0.25 versus an estimate of $-0.33.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.51 which was followed by a 0.69% increase in the share price the next day.
Here’s a look at Spero Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.04 | -0.30 | -0.54 | -0.87 |
| EPS Actual | 0.55 | -0.33 | -0.51 | -1.01 |
| Revenue Estimate | 22.87M | 5.42M | 1.15M | 2.57M |
| Revenue Actual | 47.44M | 2.01M | 1.99M | 2.07M |
To track all earnings releases for Spero Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
